Ontology-Based Combinatorial Comparative Analysis of Adverse Events Associated with Killed and Live Influenza Vaccines

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Sarntivijai, Sirarat ^a   Xiang, Zuoshuang ^b   Shedden, Kerby A ^a   Markel, Howard ^b   Omenn, Gilbert S ^a,d   Athey, Brian D ^a,c   He, Yongqun ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ADVERSE DRUG REACTION; ANAPHYLACTOID PURPURA; ARTICLE; ASTHMA; ATAXIA; BIOINFORMATICS; BLOOD PRESSURE; BRONCHITIS; BRONCHOSPASM; BURNING SENSATION; CHILL; COLD SENSATION; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CREATINE KINASE BLOOD LEVEL; CROUP; DAILY LIFE ACTIVITY; DISEASE SEVERITY; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRY THROAT; DYSARTHRIA; DYSPHAGIA; DYSPNEA; ELECTROCARDIOGRAM; ELECTROMYOGRAM; EPISTAXIS; EYE DISCHARGE; EYE IRRITATION; EYELID EDEMA; FACE SWELLING; FACIAL NERVE PARALYSIS; FATIGUE; FLUSHING; GLUCOSE BLOOD LEVEL; GUILLAIN BARRE SYNDROME; HEART PALPITATION; HEART RATE; HOT FLUSH; HUMAN; HYPERTENSION; HYPESTHESIA; HYPOREFLEXIA; IMMUNIZATION REACTION; INFECTION PREVENTION; INFLUENZA SEROLOGY; INFLUENZA VACCINATION; INJECTION SITE HEMATOMA; LARYNX SPASM; LIMB PAIN; LOBAR PNEUMONIA; LYMPHOCYTE; META ANALYSIS (TOPIC); MIGRAINE; MORBIDITY; MUSCLE WEAKNESS; MUSCULOSKELETAL PAIN; NASAL DISCOMFORT; NECK PAIN; NEURALGIA; NEUTROPHIL; NOSE OBSTRUCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OCULAR PRURITUS; OTALGIA; PAIN; PARALYSIS; PARESTHESIA; PERICARDITIS; PHARYNX EDEMA; PHOTOPHOBIA; PHYSICAL MOBILITY; PNEUMONIA; POSTNATAL DRIP; PREGNANCY TEST; PRURITUS; RANGE OF MOTION; RESPIRATORY TRACT CONGESTION; RETCHING; RHINOPHARYNGITIS; RHINORRHEA; SCORING SYSTEM; SEASONAL INFLUENZA; SENSATION OF HEAVINESS; SHOULDER PAIN; SIDE EFFECT; SIGNAL DETECTION; SINUS CONGESTION; SINUS HEADACHE; SINUSITIS; SNEEZING; STATISTICAL ANALYSIS; STRIDOR; SWELLING; THORAX PAIN; THORAX RADIOGRAPHY; THROAT TIGHTNESS; TONGUE EDEMA; TONGUE SWELLING; UPPER RESPIRATORY TRACT INFECTION; URINALYSIS; VISUAL IMPAIRMENT; WORK CAPACITY; XEROSTOMIA;

HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; VACCINES, ATTENUATED; VACCINES, INACTIVATED;

TIPULA IRIDESCENT VIRUS;

EID: 84870367610     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049941     Document Type: Article

References (54)

1. Haber P, Sejvar J, Mikaeloff Y, DeStefano F, (2009) Vaccines and Guillain-Barre syndrome. Drug Saf 32: 309-323.
2. Chen RT, Rastogi SC, Mullen JR, Hayes SW, Cochi SL, et al. (1994) The Vaccine Adverse Event Reporting System (VAERS). Vaccine 12: 542-550.
3. Botsis T, Ball R, (2011) Network analysis of possible anaphylaxis cases reported to the US vaccine adverse event reporting system after H1N1 influenza vaccine. Studies in health technology and informatics 169: 564-568.
4. Botsis T, Nguyen MD, Woo EJ, Markatou M, Ball R, (2011) Text mining for the Vaccine Adverse Event Reporting System: medical text classification using informative feature selection. Journal of the American Medical Informatics Association: JAMIA 18: 631-638.
5. Geier DA, Geier MR, (2006) A meta-analysis epidemiological assessment of neurodevelopmental disorders following vaccines administered from 1994 through 2000 in the United States. Neuro endocrinology letters 27: 401-413.
6. Woo EJ, Ball R, Burwen DR, Braun MM, (2008) Effects of stratification on data mining in the US Vaccine Adverse Event Reporting System (VAERS). Drug safety: an international journal of medical toxicology and drug experience 31: 667-674.
7. Geier MR, Geier DA, (2004) A case-series of adverse events, positive re-challenge of symptoms, and events in identical twins following hepatitis B vaccination: analysis of the Vaccine Adverse Event Reporting System (VAERS) database and literature review. Clinical and experimental rheumatology 22: 749-755.
8. Varricchio F, Iskander J, Destefano F, Ball R, Pless R, et al. (2004) Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. Pediatr Infect Dis J 23: 287-294.
9. DuMouchel W, (1999) Bayesian Data Mining in Large Frequency Tables, With an Application to the FDA Spontaneous Reporting System. The American Statistician 53.
10. Bate A, Lindquist M, Edwards IR, Olsson S, Orre R, et al. (1998) A Bayesian neural network method for adverse drug reaction signal generation. European journal of clinical pharmacology 54: 315-321.
11. Evans SJ, Waller PC, Davis S, (2001) Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiology and drug safety 10: 483-486.
12. Heeley E, Waller P, Moseley J, (2005) Testing and implementing signal impact analysis in a regulatory setting: results of a pilot study. Drug safety: an international journal of medical toxicology and drug experience 28: 901-906.
13. Egberts AC, Meyboom RH, van Puijenbroek EP, (2002) Use of measures of disproportionality in pharmacovigilance: three Dutch examples. Drug safety: an international journal of medical toxicology and drug experience 25: 453-458.
14. Brown EG, (2003) Methods and pitfalls in searching drug safety databases utilising the Medical Dictionary for Regulatory Activities (MedDRA). Drug safety: an international journal of medical toxicology and drug experience 26: 145-158.
15. He Y, Xiang Z, Sarntivijai S, Toldo L, Ceusters W (2011) AEO: A Realism-Based Biomedical Ontology for the Representation of Adverse Events. In: Smith B, editor; Buffalo, NY. pp. 309.
16. Xiang Z, Courtot M, Brinkman RR, Ruttenberg A, He Y, (2010) OntoFox: web-based support for ontology reuse. BMC Res Notes 3: 175.
17. Smith B, Ashburner M, Rosse C, Bard J, Bug W, et al. (2007) The OBO Foundry: coordinated evolution of ontologies to support biomedical data integration. Nat Biotechnol 25: 1251-1255.
18. Banks D, Woo EJ, Burwen DR, Perucci P, Braun MM, et al. (2005) Comparing data mining methods on the VAERS database. Pharmacoepidemiology and drug safety 14: 601-609.
19. Evans D, Cauchemez S, Hayden FG, (2009) "Prepandemic" immunization for novel influenza viruses, "swine flu" vaccine, Guillain-Barre syndrome, and the detection of rare severe adverse events. J Infect Dis 200: 321-328.
20. Hill AB, (1965) The Environment and Disease: Association or Causation? Proc R Soc Med 58: 295-300.
21. Saunders NR, Habgood MD, Dziegielewska KM, (1999) Barrier mechanisms in the brain, I. Adult brain. Clinical and experimental pharmacology & physiology 26: 11-19.
22. Lee GM, Greene SK, Weintraub ES, Baggs J, Kulldorff M, et al. (2011) H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project. American journal of preventive medicine 41: 121-128.
23. Maquet D, Croisier JL, Dupont C, Moutschen M, Ansseau M, et al. (2010) Fibromyalgia and related conditions: electromyogram profile during isometric muscle contraction. Joint, bone, spine: revue du rhumatisme 77: 264-267.
24. Yikilmaz A, Doganay S, Gumus H, Per H, Kumandas S, et al. (2010) Magnetic resonance imaging of childhood Guillain-Barre syndrome. Child's nervous system: ChNS: official journal of the International Society for Pediatric Neurosurgery 26: 1103-1108.
25. Hardell L, Eriksson M, (1991) The association between cancer mortality and dioxin exposure: a comment on the hazard of repetition of epidemiological misinterpretation. Am J Ind Med 19: 547-549.
26. Lee SJ, Kim YO, Woo YJ, Kim MK, Nam TS, et al. (2012) Neurologic adverse events following influenza A (H1N1) vaccinations in children. Pediatr Int.
27. Ozkan M, Tuygun N, Erkek N, Aksoy A, Yildiz YT, (2011) Neurologic manifestations of novel influenza A (H1N1) virus infection in childhood. Pediatr Neurol 45: 72-76.
28. Talukder RK, Sutradhar SR, Rahman KM, Uddin MJ, Akhter H, (2011) Guillian-Barre syndrome. Mymensingh Med J 20: 748-756.
29. Netto AB, Taly AB, Kulkarni GB, Rao UG, Rao S, (2011) Mortality in mechanically ventilated patients of Guillain Barre Syndrome. Ann Indian Acad Neurol 14: 262-266.
30. Niu M, Ball R, (2009) Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990-2007 [Vaccine 2009;27:290-297]. Vaccine 27: 6654-6655.
31. Die-Kacou H, Yavo JC, Kakou KA, Kamagate M, Balayssac E, et al. (2009) [Post-vaccinal adverse effects monitoring during national campaign of vaccination against measles in Cote d'Ivoire]. Bull Soc Pathol Exot 102: 21-25.
32. Souayah N, Nasar A, Suri MF, Qureshi AI, (2007) Guillain-Barre syndrome after vaccination in United States a report from the CDC/FDA Vaccine Adverse Event Reporting System. Vaccine 25: 5253-5255.
33. Haber P, Slade B, Iskander J, (2007) Letter to the Editor. Guillain-Barre Syndrome(GBS) after vaccination reported to the United States Vaccine Adverse Event Reporting System(VAERS) in 2004. Vaccine 25: 8101.
34. Souayah N, Nasar A, Suri MF, Qureshi AI, (2009) Guillain-Barre syndrome after vaccination in United States: data from the Centers for Disease Control and Prevention/Food and Drug Administration Vaccine Adverse Event Reporting System (1990-2005). Journal of clinical neuromuscular disease 11: 1-6.
35. Moro PL, Arana J, Cano M, Menschik D, Yue X, et al. (2012) Postlicensure Safety Surveillance for High-Dose Trivalent Inactivated Influenza Vaccine in the Vaccine Adverse Event Reporting System, 1 July 2010-31 December 2010. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America.
36. Choe YJ, Cho H, Kim SN, Bae GR, Lee JK, (2011) Serious adverse events following receipt of trivalent inactivated influenza vaccine in Korea, 2003-2010. Vaccine 29: 7727-7732.
37. Burwen DR, Ball R, Bryan WW, Izurieta HS, La Voie L, et al. (2010) Evaluation of Guillain-Barre Syndrome among recipients of influenza vaccine in 2000 and 2001. American journal of preventive medicine 39: 296-304.
38. Vellozzi C, Burwen DR, Dobardzic A, Ball R, Walton K, et al. (2009) Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring. Vaccine 27: 2114-2120.
39. Juurlink DN, Stukel TA, Kwong J, Kopp A, McGeer A, et al. (2006) Guillain-Barre syndrome after influenza vaccination in adults: a population-based study. Archives of internal medicine 166: 2217-2221.
40. Geier MR, Geier DA, Zahalsky AC, (2003) Influenza vaccination and Guillain Barre syndrome small star, filled. Clinical immunology 107: 116-121.
41. Lasky T, Terracciano GJ, Magder L, Koski CL, Ballesteros M, et al. (1998) The Guillain-Barre syndrome and the 1992-1993 and 1993-1994 influenza vaccines. The New England journal of medicine 339: 1797-1802.
42. Liang XF, Li L, Liu DW, Li KL, Wu WD, et al. (2011) Safety of influenza A (H1N1) vaccine in postmarketing surveillance in China. The New England journal of medicine 364: 638-647.
43. Baxter R, Lewis N, Bakshi N, Vellozzi C, Klein NP, (2012) Recurrent Guillain-Barre Syndrome Following Vaccination. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America.
44. Lee SJ, Kim YO, Woo YJ, Kim MK, Nam TS, et al. (2012) Neurologic adverse events following influenza A (H1N1) vaccinations in children. Pediatrics international: official journal of the Japan Pediatric Society.
45. Andrews N, Stowe J, Al-Shahi Salman R, Miller E, (2011) Guillain-Barre syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: self-controlled case series. Vaccine 29: 7878-7882.
46. Dieleman J, Romio S, Johansen K, Weibel D, Bonhoeffer J, et al. (2011) Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe. BMJ 343: d3908.
47. Sejvar JJ, Pfeifer D, Schonberger LB, (2011) Guillain-barre syndrome following influenza vaccination: causal or coincidental? Current infectious disease reports 13: 387-398.
48. Verity C, Stellitano L, Winstone AM, Andrews N, Stowe J, et al. (2011) Guillain-Barre syndrome and H1N1 influenza vaccine in UK children. Lancet 378: 1545-1546.
49. Williams SE, Pahud BA, Vellozzi C, Donofrio PD, Dekker CL, et al. (2011) Causality assessment of serious neurologic adverse events following 2009 H1N1 vaccination. Vaccine 29: 8302-8308.
50. McNeil MM, Arana J, Stewart B, Hartshorn M, Hrncir D, et al. (2012) A cluster of nonspecific adverse events in a military reserve unit following pandemic influenza A (H1N1) 2009 vaccination-Possible stimulated reporting? Vaccine.
51. Vellozzi C, Broder KR, Haber P, Guh A, Nguyen M, et al. (2010) Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010. Vaccine 28: 7248-7255.
52. Evans D, Cauchemez S, Hayden FG, (2009) "Prepandemic" immunization for novel influenza viruses, "swine flu" vaccine, Guillain-Barre syndrome, and the detection of rare severe adverse events. The Journal of infectious diseases 200: 321-8.
53. Izurieta HS, Haber P, Wise RP, Iskander J, Pratt D, et al. (2005) Adverse events reported following live, cold-adapted, intranasal influenza vaccine. JAMA: the journal of the American Medical Association 294: 2720-2725.
54. Kao CD, Chen JT, Lin KP, Shan DE, Wu ZA, et al. (2004) Guillain-Barre syndrome coexisting with pericarditis or nephrotic syndrome after influenza vaccination. Clinical neurology and neurosurgery 106: 136-138.